160 related articles for article (PubMed ID: 10050268)
21. [Hepatocellular carcinoma: a preventable cancer].
Viviani S; Jack A; Bah E; Montesano R
Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma: from gene to public health.
Montesano R; Hainaut P; Wild CP
J Natl Cancer Inst; 1997 Dec; 89(24):1844-51. PubMed ID: 9414172
[TBL] [Abstract][Full Text] [Related]
23. [Epidemiology of malignant liver tumors].
Rodella S; Picoco C
Ann Ist Super Sanita; 1996; 32(4):595-610. PubMed ID: 9382428
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma: risk factors other than HBV.
Villa E; Melegari M; Scaglioni PP; Trande P; Cesaro P; Manenti F
Ital J Gastroenterol; 1991; 23(7):457-60. PubMed ID: 1660333
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology and natural history of hepatocellular carcinoma.
McGlynn KA; London WT
Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):3-23. PubMed ID: 15757802
[TBL] [Abstract][Full Text] [Related]
26. Etiology of hepatocellular carcinoma in Africa.
Olweny CL
IARC Sci Publ; 1984; (63):89-95. PubMed ID: 6100289
[TBL] [Abstract][Full Text] [Related]
27. [Primary hepatocarcinoma. Epidemiologic case-control study in the province of Bergamo].
Colloredo Mels G; Paris B; Bertone V; Angeli G
Minerva Med; 1986 Mar; 77(9-10):297-306. PubMed ID: 3005920
[TBL] [Abstract][Full Text] [Related]
28. Diet and hepatocellular carcinoma: a case-control study in Greece.
Kuper H; Tzonou A; Lagiou P; Mucci LA; Trichopoulos D; Stuver SO; Trichopoulou A
Nutr Cancer; 2000; 38(1):6-12. PubMed ID: 11341045
[TBL] [Abstract][Full Text] [Related]
29. [Longitudinal study of aflatoxin exposure in the development of primary liver cancer in patients with chronic hepatitis].
Lu PX; Wang JB; Zhang QN; Wu Y; Sun Y; Chen TY
Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(24):1665-9. PubMed ID: 20979873
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for hepatocellular carcinoma in Guangxi, People's Republic of China.
Yeh FS; Mo CC; Yen RC
Natl Cancer Inst Monogr; 1985 Dec; 69():47-8. PubMed ID: 3010122
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
Mwangi J; Gatei DG
East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
[TBL] [Abstract][Full Text] [Related]
32. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya.
Autrup H; Seremet T; Wakhisi J; Wasunna A
Cancer Res; 1987 Jul; 47(13):3430-3. PubMed ID: 3034416
[TBL] [Abstract][Full Text] [Related]
33. [Epidemiology of hepatocellular carcinoma].
Ricca Rosellini S; Miglio F
Minerva Gastroenterol Dietol; 1991; 37(2):73-84. PubMed ID: 1660311
[TBL] [Abstract][Full Text] [Related]
34. [Epidemiological analysis of the etiological relationship between primary hepatocarcinoma and hepatitis B virus].
Ding ZR
Zhonghua Liu Xing Bing Xue Za Zhi; 1984 Jun; 5(3):146-9. PubMed ID: 6097361
[No Abstract] [Full Text] [Related]
35. [Epidemiology and diagnosis of hepatocellular carcinomas in cirrhosis].
Duvoux C
Ann Chir; 1998; 52(6):511-7. PubMed ID: 9752500
[TBL] [Abstract][Full Text] [Related]
36. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
[TBL] [Abstract][Full Text] [Related]
37. Exposure biomarkers in chemoprevention studies of liver cancer.
Wild CP; Turner PC
IARC Sci Publ; 2001; 154():215-22. PubMed ID: 11220661
[TBL] [Abstract][Full Text] [Related]
38. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
Nair S; Mason A; Eason J; Loss G; Perrillo RP
Hepatology; 2002 Jul; 36(1):150-5. PubMed ID: 12085359
[TBL] [Abstract][Full Text] [Related]
39. Aflatoxin risks and control measures.
Wogan GN
Fed Proc; 1968; 27(3):932-8. PubMed ID: 4297624
[No Abstract] [Full Text] [Related]
40. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.
Sun Z; Lu P; Gail MH; Pee D; Zhang Q; Ming L; Wang J; Wu Y; Liu G; Wu Y; Zhu Y
Hepatology; 1999 Aug; 30(2):379-83. PubMed ID: 10421643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
